The algorithm helping find an underdiagnosed heart condition
It can creep up and strike suddenly.
No, we’re not describing a predator hunting a gazelle in a nature documentary. This is how many patients experience the onset of heart disease.
Many heart conditions—from sudden cardiac arrest (SCA) to hypertrophic cardiomyopathy (HCM)—are so fatal and terrifying because they seem to appear out of nowhere.
Of course, medtech has something to say about that.
When it comes to HCM, a buzzy medical AI startup, Viz.ai, is making waves. Last month, the company received FDA clearance for an algorithm now being used by pharmaceutical giant Bristol Myers Squibb (BMS) to identify more cases of HCM.
This alliance between medtech and Big Pharma is poised to make sneaky heart disease a little less unpredictable. Join us in uncovering how the tech works—and what this move signals for the rest of our industry.Read more
This stroke survivor got her voice back after 18 years
The implications of the UK-EU Horizon deal for European medtech
Poor sleep is an underestimated health issue. These earbuds hope to solve it.
An outbreak reveals a medical technology blind spot: Tuberculosis testing
Goodbye to the colonoscopy? This engineered bacterium is the newest approach to colon cancer detection.
An ultrasound bra for easier, cheaper, and more comfortable breast cancer screening
STAY AHEAD IN MEDTECH
Subscribe to our biweekly newsletter and never miss our perspectives on top stories, the latest startup deals, fresh infographics and inspiring conversations.
Dr. Hadi Saleh is CEO of CeramTec, a leading provider of advanced ceramics for medical applications. He is driven by the idea of embracing technology for the benefit of human life.